Fuan Pharmaceutical Co., Ltd. obtained the clinical approval for the treatment of hypertension with lekadipine hydrochloride
-
Last Update: 2020-04-03
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
According to the information on CFDA website, Fuan Pharmaceutical (300194 SZ) has completed the examination and approval of lekadipine hydrochloride and its preparation for hypertension People from the company told the media that lecardine hydrochloride obtained clinical approval and it is expected that the product will be on the market for a long time "I haven't got the approval yet." According to the public information, lekadipine hydrochloride is a new generation of dihydropyridine calcium channel blocker with multiple effects, which is used to treat mild and moderate essential hypertension Compared with similar drugs, it has the characteristics of strong efficacy, long acting time and high blood vessel selectivity At present, only Chongqing shenghuaxi Pharmaceutical Co., Ltd is a manufacturer in China Fu'an pharmaceutical industry is one of the major domestic antibiotic manufacturers Its operating revenue and profit largely depend on its main product, aztreonam In order to alleviate the adverse effects of the anti drug restriction policy, the company has actively transformed its specialty drugs in recent years At present, the company has more than 30 specialty drugs reviewed by CFDA.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
